Abekah-Nkrumah, Gordon
Ofori, Charles Gyamfi
Antwi, Maxwell
Attachey, Alex Yao
de Wit, Tobias F. Rinke
Janssens, Wendy
Duah, James
Dieteren, Charlotte
Sunkwa-Mills, Gifty
Funding for this research was provided by:
PharmAccess, Ghana (PharmAccess-2021, PharmAccess-2021)
Article History
Received: 18 October 2023
Accepted: 30 August 2024
First Online: 15 September 2024
Declarations
:
: Ethical approval was sought from the Ethics Review Board of the Christian Health Association of Ghana (CHAG), with ethical approval number: CHAG-IRB-10032020. Written informed consent to participate was obtained from all participants. All methods used in the study were carried out in accordance with relevant regulations and guidelines.
: Not applicable.
: This paper was developed from a technical report that was funded by PharmAccess Ghana. Thus, authors who work for PharmAccess have a financial competing interest, in that they receive salaries as staff from PharmAccess. Notwithstanding that PharmAccess provided funding for the paper, study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit the paper for publication was mainly taken by the lead author (researcher) with contributions from co-authors outside of PharmAccess. The role of co-authors from PharmAccess as has been detailed out in the contribution section was providing comments into the study design; collection, analysis, and interpretation of data; writing of the paper to improve the quality of the paper.